What Is Steatohepatitis? Symptoms, Causes, and Treatment

Steatohepatitis is fatty liver that has gone a step further: the fat is accompanied by inflammation and injury to liver cells. It is usually tied to excess weight and blood-sugar problems rather than alcohol. Most people feel nothing for years, so it is often discovered by chance on a blood test or scan. Unlike many liver diseases, it is often reversible, and steady weight loss is the most powerful treatment.

Fatty Liver Versus Steatohepatitis

In simple fatty liver, fat collects inside liver cells but the cells themselves are not damaged.1PubMed. Histopathological findings of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis In steatohepatitis, the fat comes with inflammation and swollen, injured liver cells.1PubMed. Histopathological findings of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis That is the stage where lasting harm can start. Injured cells call in repair cells that lay down scar tissue. If inflammation continues, scarring builds slowly over years, and it is the amount of scarring, more than the fat itself, that decides your long-term risk.

Many people with simple fatty liver never develop inflammation, so hearing “fatty liver” on a scan does not mean your liver is being injured. A routine ultrasound can show fat but cannot reliably show inflammation. Telling the two apart takes further testing, such as blood scores and a stiffness scan.

Doctors now call the fatty liver condition MASLD and steatohepatitis MASH, replacing the older NAFLD and NASH.2PubMed Central. No More NAFLD: The Term Is Now MASLD. A new label, MetALD, covers people whose liver is affected by both metabolic problems and drinking.2PubMed Central. No More NAFLD: The Term Is Now MASLD. Your report may use either set of names for the same thing. Heavy drinking can cause a steatohepatitis that looks similar under the microscope, but the metabolic form works through different pathways, so the two are treated as separate diseases.3PubMed Central. Therapeutic opportunities for alcoholic steatohepatitis and nonalcoholic steatohepatitis: exploiting similarities and differences in pathogenesis3PubMed Central. Therapeutic opportunities for alcoholic steatohepatitis and nonalcoholic steatohepatitis: exploiting similarities and differences in pathogenesis

Symptoms of Steatohepatitis

Feeling fine is not reassurance. The liver has few pain nerves and copes quietly for years. Normal liver blood tests do not rule out steatohepatitis, and symptoms can’t tell you how much scarring there is. Only testing can.

Fatigue is real and common. Many people with steatohepatitis report tiredness and lower physical functioning than the general population.5PubMed Central. Health-related quality of life burden of nonalcoholic steatohepatitis: a robust pragmatic literature review The encouraging part is that quality of life improves more after weight loss in steatohepatitis than in simple fatty liver.5PubMed Central. Health-related quality of life burden of nonalcoholic steatohepatitis: a robust pragmatic literature review

Still, tiredness has many causes in people with excess weight and diabetes, including poor sleep, sleep apnea, low mood, and blood sugar swings. Fatigue alone does not point to the liver. If you are persistently exhausted, raise it with your doctor so other treatable causes get checked too.

Yellowing eyes, dark urine, or a swelling belly need prompt medical review. Confusion or drowsiness in someone with liver disease is urgent.

What Causes Steatohepatitis

The main driver is insulin resistance, where the body responds poorly to insulin in the liver, fat tissue and muscle.6PubMed Central. Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus Stressed fat tissue then releases extra fatty acids that pour into the liver.6PubMed Central. Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus The overload of fat becomes toxic to liver cells and inflames them.6PubMed Central. Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus Type 2 diabetes speeds this up and raises the chance of scarring.7Archives of Medical Science. Non-alcoholic fatty liver disease, metabolic syndrome, and type 2 diabetes mellitus: where do we stand today?

Inside the cell, excess fat strains the part that folds proteins.8PubMed. Endoplasmic reticulum stress signalling and the pathogenesis of non-alcoholic fatty liver disease When that stress can’t be relieved, the cell’s alarm response triggers inflammation and eventually cell death.8PubMed. Endoplasmic reticulum stress signalling and the pathogenesis of non-alcoholic fatty liver disease9PubMed Central. The Role of Endoplasmic Reticulum in Lipotoxicity during Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Pathogenesis10PubMed Central. Regulation of Hepatic Stellate Cell Phenotypes in MASH

Genes and the gut play a part too. Certain inherited gene variants, such as PNPLA3, raise the risk of fatty liver progressing to scarring.11PubMed. Toward Genetic Prediction of Nonalcoholic Fatty Liver Disease Trajectories: PNPLA3 and Beyond People with fatty liver are also about five times more likely to have a “leaky” gut lining.12PubMed Central. The Role of Leaky Gut in Nonalcoholic Fatty Liver Disease: A Novel Therapeutic Target Bacterial toxins from the gut can then reach the liver and fuel inflammation, especially with high-fat, high-sugar diets.13PubMed Central. Current Research on the Pathogenesis of NAFLD/NASH and the Gut–Liver Axis: Gut Microbiota, Dysbiosis, and Leaky-Gut Syndrome

Some risk factors are easy to recognize. A large waist and belly fat carry more risk than weight elsewhere. Type 2 diabetes, prediabetes, high triglycerides and high blood pressure tend to cluster with it. A family history of fatty liver or cirrhosis may point to inherited risk.

Belly fat matters because fat stored deep in the abdomen, around the organs, is more metabolically active and sends more fatty acids toward the liver than fat on the hips or thighs. Some people with a normal body weight still develop steatohepatitis, usually with a larger waist or insulin resistance, so a normal scale reading is not full protection.

Drug-induced steatohepatitis is rare and caused by only a handful of medicines.14PubMed Central. Mechanistic Review of Drug-Induced Steatohepatitis Amiodarone, a heart-rhythm drug, is one classic example.15Annals of Hepatology. Drug-induced fatty liver disease: An overview of pathogenesis and management Never stop a prescribed drug on your own because of liver worries. Do tell your doctor about every medicine and supplement you take.

How Serious Is Steatohepatitis

If inflammation continues, scarring can progress to cirrhosis, severe scarring that disrupts how the liver works.16PubMed Central. Metabolic Dysfunction-Associated Steatohepatitis and Progression to Hepatocellular Carcinoma: A Literature Review Scar tissue stiffens the liver and raises pressure in its blood vessels.17PubMed Central. Hepatocyte–hepatic stellate cell interactions in liver fibrosis: Mechanisms and therapeutic implications Steatohepatitis can also lead to liver cancer, mainly in people with advanced scarring.16PubMed Central. Metabolic Dysfunction-Associated Steatohepatitis and Progression to Hepatocellular Carcinoma: A Literature Review18PubMed Central. Natural Progression of Non-Alcoholic Steatohepatitis to Hepatocellular Carcinoma Older age, male sex and metabolic syndrome raise that cancer risk further.16PubMed Central. Metabolic Dysfunction-Associated Steatohepatitis and Progression to Hepatocellular Carcinoma: A Literature Review

Most people with steatohepatitis never develop cirrhosis, which is why the diagnosis calls for follow-up rather than alarm. Progression is usually slow, often over many years, which gives time to act, and scarring can stabilize or improve when the underlying causes are treated. People who do have cirrhosis need regular liver cancer screening, usually by ultrasound.

The heart is the bigger danger. Over nearly 30 years of follow-up, people with fatty liver disease died sooner than others, and heart disease was the main cause, ahead of cancer and liver failure.19PubMed Central. Cardiovascular Risk in Fatty Liver Disease: The Liver-Heart Axis—Literature Review Ask for blood pressure, cholesterol and blood sugar checks. Statins are generally safe for most people with fatty liver, so liver worries are not usually a reason to avoid them.

Treating Steatohepatitis With Weight Loss

After a year of lifestyle change, about 1 in 4 people saw their steatohepatitis disappear.20PubMed. Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis Among those who lost at least 5% of body weight, more than half saw it clear.20PubMed. Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis Losing at least 7% reduced fat, inflammation and cell injury.21PubMed Central. Randomized Controlled Trial Testing the Effects of Weight Loss on Nonalcoholic Steatohepatitis (NASH) At that 7% mark, though, scarring did not clearly improve.21PubMed Central. Randomized Controlled Trial Testing the Effects of Weight Loss on Nonalcoholic Steatohepatitis (NASH) Of those who lost 10% or more, 90% had their steatohepatitis clear and 45% had less scarring.20PubMed. Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis

Ten percent is hard. Only about 1 in 10 people reached it with lifestyle change alone.22PubMed Central. Nonalcoholic Fatty Liver Disease and Obesity Treatment For someone weighing 100 kg (220 lb), the target is about 10 kg (22 lb). Smaller losses still count, and medicine or surgery may help reach larger ones.

Food choices matter most where liver fat is concerned. Sugary drinks such as soda, sweetened juice and energy drinks are a leading target, because liquid sugar is easy to take in at large amounts and the liver turns fructose into fat. Whole fruit is not the concern, since it has fiber and far less sugar than juice or soda. Swapping a daily sweet drink for water or unsweetened tea is a concrete first step.

A Mediterranean-style pattern is widely recommended. It centers on vegetables, legumes, whole grains, fish and olive oil, with less red and processed meat and fewer sweets. It can lower liver fat even when weight changes only a little, so it is worth following even if the scale is slow to move. Aim for steady loss of about 0.5 to 1 kg a week, which is safer for the liver than crash dieting.

Regular activity lowers liver fat even with little weight change; around 150 minutes a week of moderate exercise is a good aim. Limit or avoid alcohol, which adds a second source of liver injury.

How Doctors Check for Steatohepatitis and Scarring

A liver biopsy shows inflammation directly, but it is used less often because it is invasive and can miss affected areas.23PubMed. Non-invasive diagnosis and monitoring of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis Doctors rely on blood scores and scans first.

The path often begins with routine liver blood tests, or an ultrasound ordered for another reason that shows a bright, fatty liver. Doctors then calculate a FIB-4 score from ordinary blood results and age, which needs no extra test and sorts people into low or higher risk of scarring. A low score is often reassuring enough for follow-up in primary care. A higher or unclear score leads to further testing, and sometimes referral to a liver specialist.

A FibroScan is an ultrasound-style scan that measures liver stiffness, a sign of scarring.24PubMed Central. Fibroscan-AST (FAST) score and other non-invasive tests for the diagnosis of fibrotic non-alcoholic steatohepatitis It takes about 10 minutes, is painless, and needs a few hours of fasting. Combined with a liver blood test, it identifies people with active disease and significant scarring better than blood scores alone such as FIB-4.25PubMed Central. FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study About 1 in 3 results fall in an in-between zone needing further tests.24PubMed Central. Fibroscan-AST (FAST) score and other non-invasive tests for the diagnosis of fibrotic non-alcoholic steatohepatitis An MRI-based version is more accurate still.24PubMed Central. Fibroscan-AST (FAST) score and other non-invasive tests for the diagnosis of fibrotic non-alcoholic steatohepatitis

Medicines and Surgery for Steatohepatitis

Resmetirom works directly on the liver by mimicking thyroid hormone there, while semaglutide works through weight loss and better metabolism.26PubMed. Resmetirom and semaglutide: next-generation therapies for metabolic-associated steatohepatitis. Opportunities, challenges and issues Both clear steatohepatitis and improve scarring in a significant share of people.26PubMed. Resmetirom and semaglutide: next-generation therapies for metabolic-associated steatohepatitis. Opportunities, challenges and issues Tirzepatide, pioglitazone, and vitamin E with pioglitazone also outperformed placebo in clearing inflammation.27PubMed Central. Comparison of pharmacological therapies in metabolic dysfunction–associated steatohepatitis for fibrosis regression and MASH resolution: Systematic review and network meta-analysis Several other promising drugs are still in trials.

These medicines are generally aimed at people with confirmed steatohepatitis and a meaningful degree of scarring, not fat alone. Your doctor will usually confirm this with a stiffness scan or other tests first. Lifestyle change continues alongside any medicine, since the drugs add to it rather than replace it.

Semaglutide is given as a regular injection, and nausea is among the more common side effects, so it is worth discussing how to manage it. These drugs work while you take them, and weight often returns if they are stopped, so treatment is generally long term. Your doctor can explain how it fits with other medicines you take, particularly for diabetes.

Surgery is typically considered for people with severe obesity, and its results last. Five years after weight-loss surgery, steatohepatitis had cleared in 84% of people.28PubMed. Bariatric Surgery Provides Long-term Resolution of Nonalcoholic Steatohepatitis and Regression of Fibrosis Scarring decreased in 70%, and improvement continued for five years.28PubMed. Bariatric Surgery Provides Long-term Resolution of Nonalcoholic Steatohepatitis and Regression of Fibrosis Advanced scarring did remain in nearly half of people who had it, despite weight loss.29PubMed. Persistence of severe liver fibrosis despite substantial weight loss with bariatric surgery Clearing the disease after surgery was linked to survival like people who never had it, while persistent disease raised death risk.30PubMed. Resolution of Metabolic Dysfunction-associated Steatohepatitis With No Worsening of Fibrosis After Bariatric Surgery Improves 15-year Survival: A Prospective Cohort Study

Steatohepatitis in Children

Children get steatohepatitis too, mainly those with obesity. It is often diagnosed before puberty, more often in boys and Hispanic children.31PubMed. Non-alcoholic steatohepatitis in children Outlook depends on how many risk factors are present and how much liver damage there is.31PubMed. Non-alcoholic steatohepatitis in children In one study, a raised AST liver enzyme was the strongest single predictor of scarring in children, though it cannot confirm scarring on its own.32PubMed Central. Nonalcoholic Steatohepatitis in Children: A Multicenter Clinicopathological Study

Because it often causes no symptoms in children either, pediatric guidelines suggest liver blood tests for children with obesity, so it is reasonable to ask the pediatrician about it. A raised liver enzyme prompts further evaluation rather than being a diagnosis on its own. Gradual weight change is the main treatment, and family-wide changes in drinks, snacks and activity work better than singling out one child.